Cui Ma
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 13
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 11
-
- Pulmonary Hypertension Research and Treatments 29
- Molecular Biology top 10%
- RNA modifications and cancer 15
- Circular RNAs in diseases 11
- Automotive Engineering top 5%
-
- Advancements in Battery Materials 18
- Advanced Battery Materials and Technologies 14
Cui Ma
121 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 147
- Cancer Research 588
- Biochemistry 155
- Pulmonary and Respiratory Medicine 687
- Molecular Biology 1.2k
- Automotive Engineering 133
Countries citing papers authored by Cui Ma
This map shows the geographic impact of Cui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui Ma more than expected).
Fields of papers citing papers by Cui Ma
This network shows the impact of papers produced by Cui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui Ma. The network helps show where Cui Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cui Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 15 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 57 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 55 | |
| 14 | 2020 | 17 | |
| 15 | 2020 | 22 | |
| 16 | 2020 | 6 | |
| 17 | 2020 | 3 | |
| 18 | 2018 | 55 | |
| 19 | 2018 | 16 | |
| 20 | 2014 | 2 |
About Cui Ma
Cui Ma is a scholar working on Cancer Research, Biochemistry and Pulmonary and Respiratory Medicine, having authored 133 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (29 papers), Advancements in Battery Materials (18 papers), RNA modifications and cancer (15 papers), Advanced Battery Materials and Technologies (14 papers), Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (13 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Circular RNAs in diseases (11 papers). The work is most often cited by research in Cancer Research (588 citations), Biochemistry (155 citations) and Pulmonary and Respiratory Medicine (687 citations). Cui Ma has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Daling Zhu, Lixin Zhang, Yong‐Ning Zhou, Xiaodong Zheng, Siyu He, Xijuan Zhao, Xin Wei, Jian Bao, Jun Ma and Xun‐Lu Li. Their work appears in journals such as European Journal of Pharmacology, Chemical Engineering Journal, American Journal of Physiology-Lung Cellular and Molecular Physiology, Hypertension and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.